Conditional Müller Cell Ablation Causes Independent Neuronal and Vascular Pathologies in a Novel Transgenic Model
暂无分享,去创建一个
Ling Zhu | Murray Killingsworth | Marcus Fruttiger | Weiyong Shen | M. Gillies | L. Sherman | Ling Zhu | M. Fruttiger | Sora Lee | M. Killingsworth | N. Barnett | Mark C Gillies | Larry S Sherman | J. K. Kirk | Nigel L Barnett | Joshua K Kirk | Sook H Chung | SoRa Lee | Nathan J Coorey | S. Chung | Weiyong Shen | N. Coorey
[1] V. Mohan,et al. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy. , 2012, Journal of diabetes and its complications.
[2] Mingyuan Wu,et al. Oxidative and endoplasmic reticulum stresses mediate apoptosis induced by modified LDL in human retinal Müller cells. , 2012, Investigative ophthalmology & visual science.
[3] J. Schulz,et al. Targeted Ablation of Oligodendrocytes Triggers Axonal Damage , 2011, PloS one.
[4] A. Tsujikawa,et al. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy. , 2011, Investigative ophthalmology & visual science.
[5] George A. Williams,et al. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration , 2011, Proceedings of the National Academy of Sciences.
[6] T. Gardner,et al. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. , 2011, Investigative ophthalmology & visual science.
[7] David Williams,et al. Retinal crystals in type 2 idiopathic macular telangiectasia. , 2010, Ophthalmology.
[8] Julian J. Nussbaum,et al. Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury , 2011, Diabetologia.
[9] R. Guymer,et al. Perifoveal müller cell depletion in a case of macular telangiectasia type 2. , 2010, Ophthalmology.
[10] T. Langmann,et al. Microglia in the healthy and degenerating retina: insights from novel mouse models. , 2010, Immunobiology.
[11] Robert Finger,et al. Structure-Function Correlation of the Human Central Retina , 2010, PloS one.
[12] Shiying Li,et al. Retinal vascular changes after glial disruption in rats , 2009, Journal of neuroscience research.
[13] N. Osborne,et al. Cellular signaling and factors involved in Müller cell gliosis: Neuroprotective and detrimental effects , 2009, Progress in Retinal and Eye Research.
[14] P. Colditz,et al. S-Adenosyl-l-methionine restores photoreceptor function following acute retinal ischemia , 2009, Visual Neuroscience.
[15] E. Levine,et al. Rlbp1 promoter drives robust Müller glial GFP expression in transgenic mice. , 2009, Investigative ophthalmology & visual science.
[16] T. Terasaki,et al. Modulation of retinal capillary endothelial cells by Müller glial cell-derived factors , 2009, Molecular vision.
[17] Philip J Rosenfeld,et al. BEVACIZUMAB (AVASTIN) THERAPY FOR IDIOPATHIC MACULAR TELANGIECTASIA TYPE II , 2009, Retina.
[18] D. Ray,et al. Microvascular P-glycoprotein expression at the blood–brain barrier following focal astrocyte loss and at the fenestrated vasculature of the area postrema , 2007, Brain Research.
[19] E. Fletcher,et al. Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. , 2007, Current pharmaceutical design.
[20] D. Antonetti,et al. Vascular permeability in ocular disease and the role of tight junctions , 2007, Angiogenesis.
[21] W. Hauswirth,et al. Molecular and cellular alterations induced by sustained expression of ciliary neurotrophic factor in a mouse model of retinitis pigmentosa. , 2007, Investigative ophthalmology & visual science.
[22] I. Scott,et al. Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[23] Peter Wiedemann,et al. Müller cells in the healthy and diseased retina , 2006, Progress in Retinal and Eye Research.
[24] D. Guidolin,et al. Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model , 2006, Diabetologia.
[25] L. Yannuzzi,et al. Idiopathic Macular Telangiectasia , 2006, Retina.
[26] Weng Tao,et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Capecchi,et al. Motoneurons and oligodendrocytes are sequentially generated from neural stem cells but do not appear to share common lineage-restricted progenitors in vivo , 2006, Development.
[28] F. Peale,et al. Cross-species Vascular Endothelial Growth Factor (VEGF)-blocking Antibodies Completely Inhibit the Growth of Human Tumor Xenografts and Measure the Contribution of Stromal VEGF* , 2006, Journal of Biological Chemistry.
[29] M. Matsumura,et al. Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy , 2004, British Journal of Ophthalmology.
[30] A. Tsujikawa,et al. Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes. , 2004, The American journal of pathology.
[31] D. Guidolin,et al. A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the Matrigel assay in vitro. , 2004, Microvascular research.
[32] D. Ray,et al. Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood‐brain barrier in the apparent absence of direct astrocytic contact , 2004, Glia.
[33] A. Vingrys,et al. Extraction and modelling of oscillatory potentials , 2004, Documenta Ophthalmologica.
[34] S. Oliet,et al. Control of Glutamate Clearance and Synaptic Efficacy by Glial Coverage of Neurons , 2001, Science.
[35] K. Valter,et al. Cellular and subcellular patterns of expression of bFGF and CNTF in the normal and light stressed adult rat retina. , 2001, Experimental eye research.
[36] T. Gardner,et al. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. , 2000, Investigative ophthalmology & visual science.
[37] Michael A. Dyer,et al. Control of Müller glial cell proliferation and activation following retinal injury , 2000, Nature Neuroscience.
[38] M. Dubois‐Dauphin,et al. Early postnatal Müller cell death leads to retinal but not optic nerve degeneration in NSE-Hu-Bcl-2 transgenic mice , 1999, Neuroscience.
[39] J. Gass,et al. Müller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacualr retinoschisis. , 1999, Archives of ophthalmology.
[40] C. Gravel,et al. Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse. , 1997, Human gene therapy.
[41] K. A. Rich,et al. Effects of Müller cell disruption on mouse photoreceptor cell development. , 1995, Experimental eye research.
[42] H. Hammes,et al. Nerve Growth Factor Prevents Both Neuroretinal Programmed Cell Death and Capillary Pathology in Experimental Diabetes , 1995, Molecular medicine.
[43] T. Mitamura,et al. Diphtheria Toxin Binds to the Epidermal Growth Factor (EGF)-like Domain of Human Heparin-binding EGF-like Growth Factor/Diphtheria Toxin Receptor and Inhibits Specifically Its Mitogenic Activity (*) , 1995, The Journal of Biological Chemistry.
[44] B. Blodi,et al. Idiopathic juxtafoveolar retinal telangiectasis , 1993 .
[45] M. Lavail,et al. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[46] B. Bonavida,et al. Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha. , 1992, Journal of immunology.
[47] I. Maxwell,et al. Cloning, sequence determination, and expression in transfected cells of the coding sequence for the tox 176 attenuated diphtheria toxin A chain , 1987, Molecular and cellular biology.
[48] J. Gass,et al. Idiopathic juxtafoveolar retinal telangiectasis. , 1982, Archives of ophthalmology.